גליבק ® 100 מ"ג

Kraj: Izrael

Język: hebrajski

Źródło: Ministry of Health

Składnik aktywny:

IMATINIB AS MESYLATE 100 MG

Dostępny od:

NOVARTIS PHARMA SERVICES AG

Kod ATC:

L01XX28

Forma farmaceutyczna:

FILM COATED TABLETS

Droga podania:

PER OS

Wyprodukowano przez:

NOVARTIS PHARMA AG, SWITZERLAND

Grupa terapeutyczna:

IMATINIB

Wskazania:

Glivec is indicated for the treatment of adult patients and children 3 years of age and above with Ph+ chronic myeloid leukaemia (Ph+ -CML) in chronic phase accelerated phase or blast crisis. Glivec is also indicated for the treatment of adult patients with Kit (CD117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (GIST). Glivec is also indicated for the treament of : Adult patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) integrated with chemotherapy. Adult patients with relapsed or refractory Ph + ALL as monotherapy. Adult patients with unresectable dermatofibrosarcoma protuberans (DFSP) and adult patients with recurrent and/or metastatic DFSP who are not eligible for surgery. Adult patients with myelodyspiastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR ( platelet - derived growth factor receptor ) gene re- arrangements. Adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic l

Data autoryzacji:

2008-12-01